Browse Contents
Special Offers
Articles submitted between January 01st to October 31st, 2018 will be published as Open Access. Open Access publishing provides greater accessibility to the article. To view some of the Open access articles in the journal, please click here
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
| Forthcoming Special Issues |
Strategies and Methods to Prevent Fluoropyrimidine-Associated ToxicitiesGuest Editor(s): Antonello Di Paolo Tentative Publication Date: October, 2017 Submit Abstract via Email Download Description |
| Published Special Issues |
Personalized Therapy in Cancer of Digestive SystemGuest Editor(s): Nelson S. Yee |
| Authors' Comments |
Clinical Cancer Drugs
,Volume 4
-Number 2
Editorial
Editorial: “Strategies and Methods to Prevent Fluoropyrimidine-associated Toxicities”
, 4(2): 73Antonello Di Paolo
DOI: 10.2174/2212697X0402180109161012
Editorial: “Strategies and Methods to Prevent Fluoropyrimidine-associated Toxicities”
Review Article
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?
, 4(2): 74 - 81Manon Launay, Joseph Ciccolini*, Anne Rodallec, Claire Fournel, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
DOI: 10.2174/2212697X04666170531080625
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 1 – Where Do We Stand?
Review Article
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World
, 4(2): 82 - 92Antonello Di Paolo*, Marzia Del Re, Elena Arrigoni, Teresa Di Desidero, Eleonora Rofi, Romano Danesi and Guido Bocci
DOI: 10.2174/2212697X04666170817124625
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World
Review Article
Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View
, 4(2): 93 - 103Laura Bertolaso* and Milena Gusella
DOI: 10.2174/2212697X04999171106143135
Fluoropyrimidine-associated Toxicities in Colorectal Cancer Patients: The Epigenetic Point of View
Review Article
Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans
, 4(2): 104 - 111Gianfranco Natale*, Antonello Di Paolo and Guido Bocci
DOI: 10.2174/2212697X04666171110190256
Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans
Research Article
Prevention of Capecitabine Toxicity Using a 5-FU Test Dose
, 4(2): 112 - 121Teresa Di Desidero, Cecilia Barbara, Paola Orlandi, Anna Fioravanti, Fotios Loupakis, Chiara Cremolini, Giacomo Allegrini, Antonello Di Paolo, Alfredo Falcone, Romano Danesi and Guido Bocci*
DOI: 10.2174/2212697X04666170504144550
Prevention of Capecitabine Toxicity Using a 5-FU Test Dose
Research Article
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
, 4(2): 122 - 128Manon Launay, Joseph Ciccolini*, Claire Fournel, Charlotte Dupuis, Nicolas Fakhry, Florence Duffaud, Sebastien Salas and Bruno Lacarelle
DOI: 10.2174/2212697X04666170817123425
Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
Review Article
Progress and Obstacles in the Application of Precision Medicine in the Management of Hepatocellular Carcinoma
, 4(2): 129 - 134Ping Wang and Xueying Sun*
DOI: 10.2174/2212697X04666170817125451
Progress and Obstacles in the Application of Precision Medicine in the Management of Hepatocellular Carcinoma
Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models
Anna R. Schreiber, Anna Nguyen, Stacey M. Bagby, John J. Arcaroli, Betelehem Yacob, Kevin Quackenbush, Joe L. Guy, Thomas Crowell, Bradley Stringer, Hadi Danaee, Thea Kalebic, Wells A. Messersmith and Todd M. Pitts
View Abstract
Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors
Atasi De Chatterjee, Debarshi Roy, Priscilla Guevara, Rituraj Pal, Mahesh Narayan, Sukla Roychowdhury and Siddhartha Das*
View Abstract
Intraoperative Sono-photodynamic Therapy for Anaplastic Astrocytoma Grade III With Transformation in Glioblastoma Grade IV
Dmitry Tzerkovsky*, Fedor Borichevsky, Yuri Grachev and Yuri Istomin
View Abstract
A novel therapeutic approach in acute promyelocytic leukemia with all-trans retinoic acid and cyclin-dependent kinase inhibitors
G. Tsolkas Papanikolaou*, D Komninou, E. Briasoulis, E. Hatzimichael and N.A. Papanikolaou
View Abstract
Currently Approved Poli (Adenosine Diphosphate-Ribose) Inhibitors In Ovarian Cancer: Current Status And Future Directions
Gonzalo Giornelli and Pablo Mando*
View Abstract
Prevalence of Neuropathy Associated With Bortezomib: A Retrospective Study
, 2017; 4(1): 69 - 72Pulivarthi Swaroopa, Mathew Josy, Ehresmann Kirsten and Gurram Murali Krishna*
DOI: 10.2174/2212697X03666161128102453
Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
, 2016; 3(2): 131 - 137G. Steven Martinez, Jeremy A. Ross and Robert A. Kirken
DOI: 10.2174/2212697X03666160610085943
A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer
, 2015; 2(2): 87 - 90Hong-tao Chen, Yi-feng Liao, Mei Xiao, Lin Ma and Hong-Yu Zhang
DOI: 10.2174/2212697X02666151026215656
Inhibition of Autophagy by Targeting ATG4B: Promises and Challenges of An Emerging Anti-cancer Strategy
, 2015; 2(1): 61 - 70Kelly Lien, Michelle Rocha, Elisa Tran, Van C. Hoang, Annabelle Chow and Urban Emmenegger
DOI: 10.2174/2212697X02666150331202809
Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
, 2014; 1(2): 116 - 126Annabelle Chow, Giulio Francia, Andrew Kouri, Christina Lee, John M. Ebos, Robert S. Kerbel and Urban Emmenegger
DOI: 10.2174/2212697X01666131218235200
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment
, 2014; 1(1): 65 - 71Bianca Maria Veneziani, Micaela Montanari, Maria Letizia Cataldo, Luigi Coppola, Agostina Nardone, Sara Corvigno, Carmine De Angelis, Grazia Arpino, Mario Giuliano, Chiara Carlomagno, Roberto Bianco and Sabino De Placido
DOI: 10.2174/2212697X113016660008
Webmaster Contact: info@benthamscience.org